BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1170 related articles for article (PubMed ID: 19698915)

  • 1. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmelanoma skin cancer.
    Lee DA; Miller SJ
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):309-24. PubMed ID: 19698913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous melanoma: detecting it earlier, weighing management options.
    Lane JE; Dalton RR; Sangueza OP
    J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation and initial management of the patient with facial skin cancer.
    Ho T; Byrne PJ
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):301-7. PubMed ID: 19698912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood melanoma.
    Jen M; Murphy M; Grant-Kels JM
    Clin Dermatol; 2009; 27(6):529-36. PubMed ID: 19880040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
    Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
    Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of microsatellites as a prognostic factor in primary malignant melanoma.
    Shaikh L; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR; Kashani-Sabet M
    Arch Dermatol; 2005 Jun; 141(6):739-42. PubMed ID: 15967920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors and improving treatment of cutaneous melanoma].
    Vihinen P; Kähäri VM; Pyrhönen S
    Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
    [No Abstract]   [Full Text] [Related]  

  • 10. Determinants of unfavorable presentation of primary cutaneous melanoma.
    Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
    J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
    [No Abstract]   [Full Text] [Related]  

  • 11. Unusual variants of malignant melanoma.
    Barnhill RL; Gupta K
    Clin Dermatol; 2009; 27(6):564-87. PubMed ID: 19880044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide excision without radiation for desmoplastic melanoma.
    Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
    Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
    Cumberland L; Dana A; Liegeois N
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with localized primary cutaneous melanoma.
    Mervic L
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):27-31. PubMed ID: 23000937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
    Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
    Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon therapy in malignant melanoma].
    Kokoschka EM; Micksche M
    Wien Med Wochenschr; 1993; 143(16-17):441-2. PubMed ID: 8273369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma of the feet: misdiagnosed and misunderstood.
    Albreski D; Sloan SB
    Clin Dermatol; 2009; 27(6):556-63. PubMed ID: 19880043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is sentinel node status predictive of overall survival in patients with melanoma?
    Carlson GW
    Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitiligo: a good prognostic factor in melanoma?
    Cunha D; Pacheco FA; Cardoso J
    Dermatol Online J; 2009 Feb; 15(2):15. PubMed ID: 19336032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.